Results 1 to 10 of about 53,272 (209)
Hepatitis Vaccines: Recent Advances and Challenges [PDF]
VaccinesViral hepatitis constitutes a substantial global public health challenge. The etiological agents, referred to as hepatitis viruses, are primarily categorized into five types: hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV ...
Mei Lu +5 more
doaj +2 more sources
Development of a stabilizer for lyophilization of an attenuated duck viral hepatitis vaccine
Poultry Science, 2010 The live attenuated vaccine against duck viral hepatitis currently available in Korea requires special freezers for storage and transportation with extra costs involved. The development of a lyophilization stabilizer for live attenuated duck viral hepatitis virus (DHV) vaccines, therefore, has been highly recommended for the wider application of the ...
M S, Kang +6 more
openaire +3 more sources
Viral evasion and challenges of hepatitis C virus vaccine development [PDF]
Current Opinion in Virology, 2016 Hepatitis C virus (HCV) is a major global disease burden, often leading to chronic liver diseases, cirrhosis, cancer, and death in those infected. Despite the recent approval of antiviral therapeutics, a preventative vaccine is recognized as the most effective means to control HCV globally, particularly in at-risk and developing country populations ...
Brian G, Pierce +2 more
openaire +4 more sources
New developments in the era of viral hepatitis vaccines
Marmara Medical Journal, 2016 Chronic hepatitis B and hepatitis C infections are major healthproblems in the world. Therefore, prevention of the transmission ofthe viral infections gets higher priority. Development of hepatitisB vaccines by recombinant technology provide higher preventionrates. However, this success could not be achieved with hepatitisC vaccine.
POYRAZ, Merve, ÖZDOĞAN, Osman Cavit
openaire +4 more sources
Plant-based vaccines against viral hepatitis: A panoptic review
World Journal of VirologyThe traditional vaccines against hepatitis have been instrumental in reducing the incidence of some types of viral hepatitis; however, the need for cost-effective, easily distributable, and needle-free vaccine alternatives has led to the exploration of plant-based vaccines.
Reka, Devanathan +1 more
openaire +3 more sources
Microorganisms, 2023 Hepatitis E virus (HEV) genotypes 3 and 4 (HEV-3 and HEV-4) cause zoonotic infection in humans, with domestic pigs and wild boars being the main reservoirs of infection.
Anastasia A. Karlsen +3 more
doaj +1 more source
[Vaccine prophylaxis of viral hepatitis B in patients with acute leukemia].
Terapevticheskii arkhiv, 2008 To assess efficacy of vaccine against viral hepatitis B (VHB) in adults after achievement of acute leukemia (AL) remission.Specific prevention of VHB was made in 30 AL patients with recombinant vaccine Engerix B by two schemes: 0-1-2-12 and 0-1-2-6 months with double adult dose 40 mcg. Efficacy of vaccination was evaluated by the titer of antibodies to
N M Gurina +3 more
openaire +3 more sources
Vaccines, 2021 Universal hepatitis B vaccination of newborns was implemented in Russia starting from 1998. From 1998 to 2019, the incidence of acute hepatitis B reduced from 43.8 to 0.57 cases per 100,000 population.
Karen K. Kyuregyan +15 more
doaj +1 more source
Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation
Viruses, 2022 The factors influencing hepatitis E virus (HEV) circulation remain largely unexplored. We investigated HEV seroprevalence in humans and the prevalence of infection in farm pigs and rabbits in different regions of the Russian Federation, as well as the ...
Mikhail I. Mikhailov +20 more
doaj +1 more source
Vaccines, 2022 The data on hepatitis A virus (HAV) seroprevalence are critical for the implementation of a universal mass vaccination (UMV) strategy. The latter has not been implemented in Russia; however, regional child vaccination programs have been adopted in some ...
Karen K. Kyuregyan +20 more
doaj +1 more source